Advertenties
14.6 Referenties
1
Coons AH et al. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 1941; 47:200-202.
2
Nakane PK and Pierce GB Jr. Enzyme labeled antibodies: Preparations and applications for the localizations of antigens. J Histochem
Cytochem 1967; 14:929-931.
3
Elias JM, Gown AM, Nakamura RM, Wilbur DC, Herman GE, Jaffe ES, Battifora H, and Brigati J. Special report: Quality control in
immunohistochemistry. Am J Clin Path 1989; 92:836.
4
Nadji M and Morales AR. Immunoperoxidase techniques: a practical approach to tumor diagnosis. ASCP Press, Chicago. 1986.
5
True LD ed. Atlas of Diagnostic Immunohistopathology. Lippincott, Philadelphia.1990.
6
Gall JG, Pardue ML. Formation of RNA-DNA hybrid molecules in cytological preparation. Proceedings of the National Academy of the
Sciences of the United States of America. 1969;63:378-383.
7
Shi S-R, Gu J, and Taylor CR. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Eaton Publishing,
Natick. 2000.
8
Miller RT, Swanson PE, and Wick MR. Fixation and epitope retrieval in diagnostic immunohistochemistry: a concise review with
practical considerations. Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):228-35.
9
Bancroft JD and Stevens A. Theory and Practice of Histological Techniques. 4th Edition. Churchill Livingstone, New York. 1996.
10
Wolff et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal
Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med 2007; 131:18–43.
11
Kiernan JA. Histological and Histochemical Methods: Theory and Practice. New York: Pergamon Press. 1981.
12
Sheehan DC. and Hrapchak BB. Theory and Practice of Histotechnology. St. Louis: C.V. Mosby Co. 1980.
13
Clinical Laboratory Improvement Amendments of 1988, Final Rule 57 FR 7163 February 28, 1992.
14
O'Leary TJ, Edmonds P, Floyd AD, Mesa-Tejada R, Robinowitz M, Takes PA, Taylor CR. Quality assurance for immunocytochemistry;
Proposed guideline. MM4-P. National Committee for Clinical Laboratory Standards (NCCLS). Wayne, PA. 1997;1-46.
15
Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and three
polyclonal antibodies. Progress in Surg Path 6:1-15. eds. Fenoglio-Preiser C, Wolff CM, Rilke F. Field & Wood, Inc., Philadelphia.
16
College of American Pathologists (CAP) Certification Program for Immunohistochemistry. Northfield IL. http://www.cap.org
17
Wilkinson DG. The theory and practice of in situ hybridisation. In: Wilkinson DG. (ed.) In Situ Hybridization A practical approach. 2nd
Edition. New York: Oxford University Press, 1998, pp.18-20.
18
Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Lab Med 1983; 14:767.
19
Omata M, Liew CT, Ashcavai M, and Peters RL. Nonimmunologic binding of horseradish peroxidase to hepatitis B surface antigen: a
possible source of error in immunohistochemistry. Am J Clin Path 1980;73:626.
20
Wilkinson DG. In situ hybridization: A practical approach. 2nd Edition. Oxford University Press, Oxford. 1998.
21
Weiss LM, Chen Y. Effects of different fixatives on detection of nucleic acids from paraffinembedded tissues by in situ hybridization
using oligonucleotide probes. The Journal of Histochemistry and Cytochemistry. 1991;39(9):1237-1242.
22
Pontius CA, Murphy KA, Novis DA and Hansen AJ. CLIA Compliance Handbook: The Essential Guide for the Clinical Laboratory. 2nd
Edition. Washington G-2 Reports, New York. 2003.
BOND 7 handleiding, 49.7556.508 A06
Copyright © 2023 Leica Biosystems Melbourne Pty Ltd
14 BOND-reagentia gebruiken
342
Advertenties
